The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Zanzalintinib versus everolimus in patients with previously treated advanced neuroendocrine tumors: The phase 2/3, randomized STELLAR-311 trial.
 
Jennifer Chan
Stock and Other Ownership Interests - Merck
Honoraria - Ipsen
Consulting or Advisory Role - Boehringer Ingelheim; Curium Pharma; Lantheus Medical Imaging; Pfizer (I)
Research Funding - Camurus; Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from UpToDate for authorship
Travel, Accommodations, Expenses - Ipsen
 
Jonathan Strosberg
Consulting or Advisory Role - Boehringer Ingelheim; Exelixis
Research Funding - Alphamedix (Inst); ITM Solucin (Inst); Novartis (Inst); RayzeBio (Inst)
 
Changhoon Yoo
Stock and Other Ownership Interests - OncoCross
Honoraria - AstraZeneca; Boehringer Ingelheim; Boryung Pharmaceuticals; Bristol-Myers Squibb; Eisai; Elevar therapeutics; Ipsen; MSD Oncology; Novartis; SERVIER
Consulting or Advisory Role - Abbisko Therapeutics; Qurient
Research Funding - AstraZeneca; Boehringer Ingelheim; Boryung Pharmaceuticals; Eisai; Lunit
 
Simron Singh
Employment - Sanofi (I)
Honoraria - Advanced Accelerator Applications/Novartis; IPSEN
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Camurus; IPSEN; ITM Isotope Technologies Munich; McKesson; Sanofi
 
Zhong Wang
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Laura Sierra
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis; Incyte
Travel, Accommodations, Expenses - Exelixis
 
Ellen Bolotin
Employment - Exelixis
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Gilead Sciences (Inst); Ipsen (Inst); Ipsen (Inst); ITM Solucin (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Eisai; Gilead Sciences; Ipsen; Pfizer